Factitious hyperthyroidism causing acute myocardial infarction.
Myocardial ischemia is a rare but severe and possibly life threatening manifestation of hyperthyroidism, but does not usually result in persistent ischemia. We report on a 71-year-old woman who had undergone total thyroidectomy with subsequent irradiation because of follicular carcinoma 3 years ago. Since then, she had been maintained on oral levothyroxine replacement therapy at a dose of 0.15 mg alternating with 0.2 mg daily. When latent hypothyroidism became evident despite replacement therapy, the dose of levothyroxine was increased to 0.3 mg a day. Three weeks later, the patient suffered from an acute posterior myocardial infarction, although she had no previous history of coronary artery disease. Subsequent coronary arteriograms revealed no evidence of disease of the major vessels. Myocardial scintigraphy 3 weeks after infarction still revealed a persistent perfusion defect. Since it is known that thyroid hormones increase oxygen demand, the rapid elevation of oxygen utilization caused by thyrotoxicosis factitia is likely to be responsible for this patient's myocardial infarction. The case illustrates that a sudden increase in levothyroxine replacement dose should be avoided.
Locker
G J
GJ
Department of Internal Medicine I, University of Vienna, Austria.
Kotzmann
H
H
Frey
B
B
Messina
F C
FC
Sterz
F R
FR
Weissel
M
M
Laggner
A N
AN
D000208:Acute Disease; D000368:Aged; D005162:Factitious Disorders / Q000150:complications*; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications* / Q000188:drug therapy; D009203:Myocardial Infarction / Q000139:chemically induced*; D013965:Thyroidectomy; D013971:Thyrotoxicosis / Q000139:chemically induced / Q000150:complications; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use
D013972:Thyrotropin; D013974:Thyroxine